AAHRPP Accredits NIH and first Middle Eastern Organization
AAHRPP announced it has accredited four more organizations
The Association for the Accreditation of Human Research Protection Programs (AAHRPP) announced it has accredited four more organizations—including the National Institutes of Health, the first hospital in the Middle East, a second in Taiwan, and a world renowned children’s research hospital. AAHRPP’s accreditation and standards are developed to help protect research participants.
The newly accredited organizations are:
- King Fahad Specialist Hospital-Dammam, Dammam, Saudi Arabia
- National Institutes of Health, Bethesda, Md.
- St. Jude Children’s Research Hospital, Memphis, Tenn.
- Taipei Medical University Hospital, Taipei, Taiwan
Read the full release here.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Phase III PROMINENT Trial Initiated to Evaluate Felzartamab for Primary Membranous Nephropathy
June 30th 2025The global Phase III PROMINENT trial has begun dosing patients to evaluate felzartamab in treating primary membranous nephropathy, a serious autoimmune kidney disorder with no FDA-approved therapies.
Funding Cuts Threaten Diversity in Clinical Research
June 27th 2025In this video interview, Kyle McAllister, co-founder, CEO, Trially, discusses how recent federal funding cuts are likely to undermine research focused on underrepresented populations, and why long-term investment in community-based studies is essential to closing persistent health equity gaps.
